Skip to content

New for FY2027 ICD-10-CM · October 1, 2026

QA1.791: Familial cancer syndrome with pathogenic BRCA2 mutation

By the HCC Buddy Coding Team

The official ICD-10-CM descriptor is Familial cancer syndrome with pathogenic BRCA2 mutation. The FY2027 annual edition starts October 1, 2026. Check the edition that applies to the encounter or inpatient discharge, including any April update.

Billable code. Verified against the official FY2027 order file.

CMS-HCC V28

Not in the current CMS mapping file (FY2027-new)

CMS-HCC V24

Not in the current CMS mapping file (FY2027-new)

ESRD

Not in the current CMS mapping file (FY2027-new)

PACE

Not in the current CMS mapping file (FY2027-new)

RxHCC

Not in the current CMS mapping file (FY2027-new)

HHS-HCC

Not in the current CMS mapping file (FY2027-new)

FY2027 Tabular instructions

Instructions below include applicable chapter, section and parent-code notes. Each note identifies where it appears in the official source.

Instructional note

Codes from this chapter are not for use on maternal records

Source: Q00-QA1 (chapter, inherited).

Excludes2

inborn errors of metabolism (E70-E88)

Source: Q00-QA1 (chapter, inherited).

Code also

, if applicable, any associated conditions, such as:

Source: QA1 (category, inherited).

Code also

genetic susceptibility to malignant neoplasm by site (Z15.0-)

Source: QA1 (category, inherited).

Code also

malignant neoplasms (C00.0-C96.9)

Source: QA1 (category, inherited).

Code also

personal history of malignant neoplasm (Z85.-)

Source: QA1 (category, inherited).

Excludes2

multiple endocrine neoplasia [MEN] syndromes (E31.2-)

Source: QA1 (category, inherited).

Instructional note

BRCA2-cancer predisposition syndrome

Source: QA1.791 (self, direct).

Instructional note

Hereditary breast and ovarian cancer syndrome with pathogenic BRCA2 mutation

Source: QA1.791 (self, direct).

Source: CMS FY2027 Tabular List and Alphabetic Index.

Open Tabular instructions and code details

Compare the FY2027 additions, removals and billable-status changes

What does QA1.791 mean in FY2027?

The official ICD-10-CM descriptor is Familial cancer syndrome with pathogenic BRCA2 mutation. The FY2027 annual edition starts October 1, 2026. Check the edition that applies to the encounter or inpatient discharge, including any April update.

When did QA1.791 become an ICD-10-CM code?

QA1.791 is new for FY2027 ICD-10-CM, effective October 1, 2026. It is absent from the FY2026 April order file. Use the code set that applies to the encounter or inpatient discharge date, and check the official Tabular instructions.

Is QA1.791 billable in FY2027?

The FY2027 order file marks QA1.791 as billable. Check the complete Tabular instructions and documentation before assigning it.

Does QA1.791 map to an HCC?

QA1.791 is not in the current CMS mapping file (it is new for FY2027), and CMS has not yet published payment year 2028 mappings. No HCC category or RAF coefficient is shown.

Source: CMS FY2027 ICD-10-CM order file. Payment model: CMS CY 2027 Rate Announcement. Read the FY2027 Official Guidelines.